ADJUVANT TAMOXIFEN IN BREAST-CANCER

被引：1

作者：

JAKESZ, R ^{[1
]}

LIPPMAN, ME ^{[1
]}

机构：

[1] NCI,BREAST CANC SECT,BETHESDA,MD 20014

来源：

CANCER TREATMENT REVIEWS | 1984年 / 11卷 / 04期

关键词：

D O I：

10.1016/0305-7372(84)90032-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：321 / 323

页数：3

共 16 条

[1]

BONADONNA G, 1977, CANCER-AM CANCER SOC, V39, P2904, DOI 10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO

[2]

2-8

[3]

COLE MP, 1970, CLIN MANAGEMENT ADV, P2

[4] INFLUENCE OF TUMOR ESTROGEN AND PROGESTERONE-RECEPTOR LEVELS ON THE RESPONSE TO TAMOXIFEN AND CHEMOTHERAPY IN PRIMARY BREAST-CANCER [J].

FISHER, B ;

REDMOND, C ;

BROWN, A ;

WICKERHAM, DL ;

WOLMARK, N ;

ALLEGRA, J ;

ESCHER, G ;

LIPPMAN, M ;

SAVLOV, E ;

WITTLIFF, J ;

FISHER, ER ;

PLOTKIN, D ;

BOWMAN, D ;

WOLTER, J ;

BORNSTEIN, R ;

DESSER, R ;

FRELICK, R .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (04) :227-241

[5]

FISHER B, 1977, CANCER-AM CANCER SOC, V39, P2883, DOI 10.1002/1097-0142(197706)39:6<2883::AID-CNCR2820390676>3.0.CO

[6]

2-9

[7]

JONAT W, 1983, 13TH P INT C CHE 271, P19

[8]

LONGUEVILLE J, 1983, 13TH P INT C CHE 271, P23

[9]

MCGUIRE WL, 1977, CANCER-AM CANCER SOC, V39, P2934, DOI 10.1002/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO

[10]

2-P

← 1 2 →